About Aimm Therapeutics


Vacancy: Technician A / B
Cell biology / Molecular biology / Immuno-Oncology field

AIMM Therapeutics BV is an Amsterdam based biotech company that develops human monoclonal antibodies for the treatment of cancer. AIMM was established thirteen years ago on the belief that scientists could harness the power of specific immune cells to develop clinically relevant antibody therapies while avoiding the inefficiencies inherent to other techniques. Today this proprietary platform technology is well validated as evidenced by the two AIMM antibodies now in human clinical trials and the deep pipeline that AIMM is currently advancing in cancer.

We have an opportunity for a highly motivated and experienced technician to strengthen our team. The candidate will employ a wide range of techniques including cell culture, flow cytometry, cell-based assays, antibody production and purification and binding assays such as ELISA. The candidate will routinely use state-of-the art equipment to validate AIMM’s novel therapeutic antibodies for treatment of cancer and may also support the team in programs to perform and analyze early stage preclinical research in vivo.

A bachelor (HBO) degree in molecular biology, biochemistry, cell biology or immunology, and proven ability to independently execute and interpret experiments. There is a strong preference for applicants that hold a license to perform animal research (Dutch Art. 12/6 or European equivalent) and have extensive hands-on expertise with performing mice experiments. Effective communication skills in English and the ability to successfully operate in a multifunctional team are essential.

The appointment with AIMM Therapeutics BV will initially be for 12 months, with prospects for a permanent position being dependent on the progress made within the project and on developments within the company. Salary is commensurate with position and experience.

More information about the position can be obtained from Arjen Bakker ( Please send your application in English together with CV and names of preferably three references (including email address and phone number) before March 16, 2018 to:, regular mail: AIMM Therapeutics BV, Meibergdreef 59, 1105 BA, Amsterdam.